Radiopharmaceuticals for nuclear imaging are essentially targeting molecules, labeled with short-lived radionuclides (eg, F-18 for PET). A significant drawback of radiopharmaceuticals development is the difficulty to access radiolabeled molecule libraries for initial in vitro evaluation, as radiolabeling has to be optimized for each individual molecule. The present paper discloses a method for preparing libraries of 18F-labeled radiopharmaceuticals ...
